For an optimal site experience, we recommend using a different browser.
Using Internet Explorer may prevent you from accessing Chubb.com, and some site features may not function as expected.

X
skip to main content

When the pandemic struck in 2020, Chubb and legal partner Kennedys produced a series of reports  exploring the impact it was having on the life science industry through the lenses of clinical trials, medical devices, telehealth, genomics and the supply chain.

Looking back at the past two years, the industry has, by and large, proved successful at managing the most significant risks faced. It has also demonstrated its capabilities during an extraordinary time; producing vaccines at record speed and rapidly delivering solutions – from telehealth to medical devices and genomic surveillance – that have helped us through this difficult period. Now the life science sector is building on that foundation to improve healthcare and preparedness for future pandemics, while continuing to battle COVID-19.

 

Read “The new normal in life science” report for insights on how those changes played out in the medium term. Which innovations have become part of the new normal and where did things go wrong? From the new strength and capacity that has been built in telehealth and clinical trials, to the lessons that have been learnt for future pandemics on medical devices and supply chains.

Key takeaways

  • Supply chain visibility is now a key focus at c-level, enabled by technology.
  • Decentralised trials could be here to stay but decentralising patient recruitment is still a way off.
  • Genomic research still has a lot more to offer during this pandemic.
  • Research needs to be more inclusive to ensure the benefits of genomics are enjoyed by all.
  • Fostering innovation in the context of remote working is the next challenge.

The New Normal in Life Science

 

 

Read more reports in the ‘Life Science in the era of pandemics’ series:

Lessons from the Supply Chain
Emerging Risks in COVID-19 Clinical Trials
Making Medical Devices During a Pandemic
Fighting COVID-19 with genomics
The Great Telehealth Experiment


This content is brought to you by Chubb Insurance Malaysia Berhad, Registration No. 197001000564 (9827-A) (“Chubb”) as a convenience to readers and is not intended to constitute advice or recommendations upon which a reader may rely. Any references to insurance cover are general in nature only and may not suit your particular circumstances. Chubb does not take into account your personal objectives, financial situation or needs and any insurance cover referred to is subject to the terms, conditions and exclusions set out in the relevant policy wording. Please obtain and read carefully the relevant insurance policy before deciding to acquire any insurance product. A policy wording can be obtained at www.chubb.com/my, through your broker or by contacting any of the Chubb offices or Chubb agents. Chubb makes no warranty or guarantee about the accuracy, completeness, or adequacy of this content. It is the responsibility of the reader to evaluate the quality and accuracy of material herein.

© 2022 Chubb. Not all coverages available in all jurisdictions. Chubb® and its respective logos, and Chubb. Insured.℠  are protected trademarks of Chubb.

Tips and Resources

We help you stay ahead and informed with these helpful tips and tricks

Have a question or need more information?

Contact us to find out how we can help you get covered against potential risks